Literature DB >> 6392809

Response, regulation, and actions of vasopressin during exercise: a review.

C E Wade.   

Abstract

Plasma concentrations of vasopressin (antidiuretic hormone), a powerful pressor agent and primary regulator of body fluid homeostasis, are elevated in a dose-related fashion to increases in exercise intensity. The response of plasma vasopressin levels to exercise is not modified by gender, but is reduced with training at absolute submaximal exercise intensities. However, the duration of the exercise and hydration status of the subject alters the observed increase. The increase in plasma vasopressin concentrations during exercise may be mediated by a variety of factors: plasma osmolality, blood pressure, blood volume, plasma concentrations of angiotensin II, psychological variables, and peripheral nerve stimulation. Furthermore, decreases in the metabolism of vasopressin, due to alterations in renal and hepatic blood flow during exercise, may contribute to the increase in plasma concentrations. Although plasma vasopressin concentrations are elevated during exercise, there is no definitive effect during exercise, as the excretion rate of free water is increased, sweat rate and composition are not changed, and a role in plasma volume regulation is dubious. Thus, the function of the elevation in plasma vasopressin levels during exercise is unclear at the present time.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6392809     DOI: 10.1249/00005768-198410000-00015

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  21 in total

1.  Fluid replacement beverages and maintenance of plasma volume during exercise: role of aldosterone and vasopressin.

Authors:  D Criswell; K Renshler; S K Powers; R Tulley; M Cicale; K Wheeler
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1992

Review 2.  Interactions of physical training and heat acclimation. The thermophysiology of exercising in a hot climate.

Authors:  Y Aoyagi; T M McLellan; R J Shephard
Journal:  Sports Med       Date:  1997-03       Impact factor: 11.136

3.  Fluid balance and renal response following dehydrating exercise in well-trained men and women.

Authors:  N S Stachenfeld; G W Gleim; P M Zabetakis; J A Nicholas
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1996

4.  Neuronal activity of the cat supraoptic nucleus is influenced by muscle small-diameter afferent (groups III and IV) receptors.

Authors:  H Kannan; H Yamashita; K Koizumi; C M Brooks
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

Review 5.  Hormonal alterations due to exercise.

Authors:  J C Bunt
Journal:  Sports Med       Date:  1986 Sep-Oct       Impact factor: 11.136

6.  Activity, energy intake, obesity, and the risk of incident kidney stones in postmenopausal women: a report from the Women's Health Initiative.

Authors:  Mathew D Sorensen; Thomas Chi; Nawar M Shara; Hong Wang; Ryan S Hsi; Tonya Orchard; Arnold J Kahn; Rebecca D Jackson; Joe Miller; Alex P Reiner; Marshall L Stoller
Journal:  J Am Soc Nephrol       Date:  2013-12-12       Impact factor: 10.121

Review 7.  Effects of exercise on atrial natriuretic factor. Release mechanisms and implications for fluid homeostasis.

Authors:  B J Freund; C E Wade; J R Claybaugh
Journal:  Sports Med       Date:  1988-12       Impact factor: 11.136

Review 8.  The induction and decay of heat acclimatisation in trained athletes.

Authors:  L E Armstrong; C M Maresh
Journal:  Sports Med       Date:  1991-11       Impact factor: 11.136

9.  Effects of treadmill running and swimming on plasma and brain vasopressin levels in rats.

Authors:  F Ghaemmaghami; G Gauquelin; C Gharib; D Yoccoz; D Desplanches; R Favier; A M Allevard
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1987

10.  Post-exercise hypotension: the effects of epanolol or atenolol on some hormonal and cardiovascular variables in hypertensive men.

Authors:  R G Wilcox; T Bennett; I A Macdonald; F Broughton Pipkin; P H Baylis
Journal:  Br J Clin Pharmacol       Date:  1987-08       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.